- Report
- January 2020
- 473 Pages
Global
From €4528EUR$4,899USD£3,817GBP
- Report
- October 2018
- 450 Pages
Global
From €3234EUR$3,499USD£2,726GBP
- Report
- March 2024
- 329 Pages
Global
From €5341EUR$5,981USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5341EUR$5,981USD£4,350GBP
- Report
- March 2022
- 518 Pages
Global
From €4910EUR$5,498USD£3,999GBP
- Report
- May 2022
- 100 Pages
Global
From €1571EUR$1,700USD£1,324GBP
- Report
- May 2024
- 387 Pages
Global
From €4575EUR$4,950USD£3,857GBP
- Report
- February 2022
- 232 Pages
Global
From €4575EUR$4,950USD£3,857GBP
- Report
- March 2019
- 170 Pages
Global
From €2542EUR$2,750USD£2,143GBP
- Report
- December 2018
- 259 Pages
Global
From €2542EUR$2,750USD£2,143GBP
- Report
- September 2023
- 234 Pages
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- January 2024
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- December 2023
- 217 Pages
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- June 2023
- 235 Pages
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- June 2023
- 200 Pages
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- April 2022
- 230 Pages
Global
From €4482EUR$4,850USD£3,779GBP
- Report
- April 2022
- 120 Pages
Global
From €3558EUR$3,850USD£3,000GBP
- Report
- April 2022
- 250 Pages
Global
From €6331EUR$6,850USD£5,337GBP
- Report
- January 2022
- 100 Pages
Global
€3558EUR$3,850USD£3,000GBP
- Report
- December 2021
- 170 Pages
Global
€3558EUR$3,850USD£3,000GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more